Clinical Trials Arena August 6, 2024
Robert Barrie

Founder and owner Elon Musk said the implantation went “extremely well” but remained tight lipped on further details.

Neuralink has successfully implanted a second patient with its brain-chip device, according to the company’s owner Elon Musk.

The brain-computer interface (BCI) is designed to give paralysed people the ability to control external secondary devices with thoughts.

Musk announced the news on a podcast, saying the procedure had gone “extremely well”. The start-up founder unveiled few other details, stating only the second participant had a spinal cord injury similar to the first patient implanted with the device earlier this year.

The device uses 1,024 electrodes to detect neural activity – Musk said that 400 of the implanted electrodes in the second patient...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Medical Devices, Technology
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article